Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG)-Reference-Cited by-同舟云学术

Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG)

Published:2024-08-14 Issue: Volume: Page:1-4
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kastritis Efstathios¹^ORCID,Katodritou Eirini²^ORCID,Badelita Sorina³,Bila Jelena⁴,Seval Güldane Cengiz⁴,Cvetkovic Zorica⁵,Coriu Daniel⁶,Spanoudakis Emmanouil⁷,Dalampira Dimitra²,Sretenovic Aleksandra⁸,Sevastoudi Aggeliki²,Bojan Anca⁹,Mitrovic Marko⁸,Danaila Catalin¹⁰,Gavriatopoulou Maria¹,Roussou Maria¹,Charalampous Charalampos¹¹¹,Terpos Evangelos¹,Beksac Meral⁵,Dimopoulos Meletios A.¹

Affiliation:

1. Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

2. Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece

3. Department of Hematology, Fundeni Clinical Institute, Bucharest, Romania

4. Department of Hematology, Ankara University, Ankara, Turkey

5. Department of Hematology Clinical Hospital Center Zemun, University of Belgrade, Serbia

6. Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

7. Department of Hematology, University Hospital of Alexandroupolis, Alexandroupolis, Greece

8. Clinic of Hematology, University Clinical Center of Serbia, University of Belgrade, Medical Faculty, Belgrade, Serbia

9. Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

10. Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania

11. Department of Medicine, MedStar Georgetown University Hospital, DC, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2391900

Reference17 articles.

1. International Staging System for Multiple Myeloma

2. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

3. Chromosome 1q21 aberrations identify ultra high‐risk myeloma with prognostic and clinical implications

4. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

5. Evaluation of the R2‐ISS in real‐world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202)